Natural Molecules & Phytochemical Delivery
Making plant-derived actives clinically relevant through advanced nanotechnology.
A platform dedicated to unlocking the therapeutic potential of natural molecules — improving their bioavailability, stability, and clinical impact through precision delivery design.
The flagship is a curcumin-loaded SLN platform with high bioavailability and aqueous stability, patented in India, USA, Canada, and Europe. It is formulated as oral shots, dispersible granules, and topical applications across multiple routes of administration.
Other systems include a polyherbal formulation for hemorrhoids (multi-pathway pleuropharmacological approach); inhalable nano-herbal formulations for acute lung injury and asthma with demonstrated anti-inflammatory and antimicrobial potential; a chlorhexidine–natural actives mouthwash for periodontitis; ginger extract microbeads for gastric ulcers; colon-targeted multiparticulate beads for inflammation and colorectal cancer; and a bioactives-based composite scaffold for periodontitis.
Live probiotics-based vaginal suppositories for candida infection reflect the platform's broader scope in microbiome-informed therapeutics.
Patents
- US 12599572 B2 — Solid lipid nanoparticles of curcuma (USA, granted 2026)
- 524699 — Solid lipid nanoparticles of curcumin (India, granted 2024)
- 417693 — Topical curcumin formulation (India, granted 2023)
- 547637 — Probiotic and curcumin wound dressing (India, granted 2024)
- 564378 — Berberis extract nano-formulation (India, granted 2025)
- 489390 — Process for preparing nanoformulation for delivery of berbamine (India, granted 2023)
- CA 3,134,798 — Solid lipid nanoparticles of curcuma (Canada, filed 2021)
- EP 198912883 — Solid lipid nanoparticles of curcuma (Europe, filed 2021)
- US 18/276,232 — Berberis extract nano-formulation (USA, filed 2023)